Note 4 – Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category
as of September 28, 2024 and September 30, 2023 (in millions):

Adjusted
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Cash and
Cash
Equivalents

Current
Marketable
Securities

Non-Current
Marketable
Securities

2024

$  27,199  $

—  $

—  $  27,199  $

27,199  $

—  $

Cash